University Of California, San Diego
Clinical trials sponsored by University Of California, San Diego, explained in plain language.
-
New transplant method offers hope for blood cancer patients
Disease control TerminatedThis study tested a new way to do bone marrow transplants for people with blood cancers like leukemia. It used a partially matched donor and a drug called cyclophosphamide after the transplant to help prevent rejection. The goal was to see if patients could survive at least 180 d…
Phase: PHASE2 • Sponsor: University of California, San Diego • Aim: Disease control
Last updated May 26, 2026 04:17 UTC
-
New drug cocktail shows promise for Hard-to-Treat myeloma
Disease control TerminatedThis study tested a combination of four drugs (daratumumab, ixazomib, pomalidomide, and dexamethasone) in 23 people with multiple myeloma that had come back or stopped responding to earlier treatments. The goal was to see how many patients responded to the therapy. The trial was …
Phase: PHASE2 • Sponsor: University of California, San Diego • Aim: Disease control
Last updated May 26, 2026 04:12 UTC
-
CBD trial for emotional blindness in HIV patients shows promise
Symptom relief TerminatedThis study tested whether cannabidiol (CBD) can help people living with HIV who have alexithymia—a condition that makes it hard to recognize and describe emotions. Participants took either CBD or a placebo for 4 weeks. The goal was to see if CBD improves emotional awareness and r…
Phase: PHASE2 • Sponsor: University of California, San Diego • Aim: Symptom relief
Last updated May 15, 2026 11:53 UTC